`Filed: September 16, 2016
`
`
`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`________________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`________________
`
`AMNEAL PHARMACEUTICALS LLC and PAR PHARMACEUTICAL, INC.
`
`Petitioners,
`
`v.
`
`JAZZ PHARMACEUTICALS, INC.
`
`Patent Owner
`
`________________
`
`Case IPR2015-01903
`Patent 8,731,963
`________________
`
`JAZZ PHARMACEUTICALS, INC.’S UPDATED MANDATORY
`NOTICES PURSUANT TO 37 C.F.R. § 42.8(a)(3)
`
`
`
`
`
`
`
`Case IPR2015-01903
`Patent 8,731,963
`Patent Owner Updated Mandatory Notices
`
`
`Patent Owner hereby updates its mandatory notices concerning back-up
`
`counsel and service information pursuant to 37 C.F.R. § 42.8(b)(3)-(4).
`
`Specifically, Jazz Pharmaceuticals, Inc. updates its Mandatory Notices due
`
`to its addition of Gabriel P. Brier (Reg. No. 55,026) and David B. Cochran (Reg.
`
`No. 44,114) as additional back-up counsel. Lead counsel, F. Dominic Cerrito, and
`
`back-up counsel, Evangeline Shih and Frank C. Calvosa, will remain as counsel in
`
`this proceeding. John V. Biernacki is no longer counsel for Patent Owner. Contact
`
`information for the two additional back-up counsel is:
`
`Contact Information:
`
`Gabriel P. Brier
`
`Quinn Emanuel Urquhart & Sullivan, LLP
`
`51 Madison Avenue, 22nd Floor
`
`New York, NY 10010
`
`Phone: (212) 849-7000
`
`Fax: (212) 849-7100
`
`Email: gabrielbrier@quinnemanuel.com
`
`David B. Cochran
`
`Jones Day
`
`North Point
`
`901 Lakeside Avenue
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Case IPR2015-01903
`Patent 8,731,963
`Patent Owner Updated Mandatory Notices
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Cleveland, Ohio 44114
`
`Phone: (216) 586-3939
`
`Fax: (216) 579-0212
`
`Email: dcochran@jonesday.com
`
`Date: September 16, 2016
`
`
`
`
`
` Respectfully submitted,
`
`By: /F. Dominic Cerrito (Reg. No. 38,100)/
` F. Dominic Cerrito (Reg. No. 38,100)
` Evangeline Shih (Reg. No. 50,170)
`Gabriel P. Brier (Reg. No. 55,026)
` Frank C. Calvosa (Reg. No. 69,064)
`QUINN EMANUEL URQUHART &
`SULLIVAN, LLP
`51 Madison Avenue, 22nd Floor
`New York, NY 10010
`General Tel: (212) 849-7000
`Fax: (212) 849-7100
`nickcerrito@quinnemanuel.com
`evangelineshih@quinnemanuel.com
`gabrielbrier@quinnemanuel.com
`frankcalvosa@quinnemanuel.com
`
`David B. Cochran (Reg. No. 44,114)
`JONES DAY
`North Point
`901 Lakeside Avenue
`Cleveland, Ohio 44114
`General Tel: (216) 586-3939
`Fax: (216) 579-0212
`dcochran@jonesday.com
`
`Attorneys for Jazz Pharmaceuticals, Inc.
`
`
`
`
`
`
`
`
`
`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`________________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`________________
`
`AMNEAL PHARMACEUTICALS LLC and PAR PHARMACEUTICAL, INC.
`
`Petitioners,
`
`v.
`
`JAZZ PHARMACEUTICALS, INC.
`
`Patent Owner
`
`________________
`
`Case IPR2015-01903
`Patent 8,731,963
`________________
`
`CERTIFICATE OF SERVICE
`
`
`
`
`
`
`
`
`
`
`
`CERTIFICATE OF SERVICE
`
`Pursuant to 37 C.F.R. § 42.6(e), the undersigned hereby certifies that JAZZ
`
`PHARMACEUTICALS, INC.’S UPDATED MANDATORY NOTICES
`
`PURSUANT TO 37 C.F.R. § 42.8(a)(3) were served on September 16, 2016 by
`
`filing this document through the Patent Review Processing System, as well as e-
`
`mailing a copy to mruedy@meiplaw.com, smaddox@meiplaw.com,
`
`bradford.frese@arentfox.com, janine.carlan@arentfox.com,
`
`richard.berman@arentfox.com, and XYREM@arentfox.com.
`
`
`Date: September 16, 2016
`
`
` Respectfully submitted,
`
`By: /F. Dominic Cerrito (Reg. No. 38,100)/
` F. Dominic Cerrito (Reg. No. 38,100)
` QUINN EMANUEL URQUHART &
` SULLIVAN, LLP
` 51 Madison Avenue, 22nd Floor
` New York, NY 10010
` General Tel: (212) 849-7000
`Fax: (212) 849-7100
`nickcerrito@quinnemanuel.com
`
`Lead Counsel for
`Jazz Pharmaceuticals, Inc.